UCT moved from 121st to 103rd position in the 2021 US News & World Report Best Global Universities rankings, tied with Radboud University Nijmegen in the Netherlands, and was ranked in the top 100 for six subjects, including an outstanding top 10 ranking for infectious diseases.
The COVID-19 pandemic has directly affected more than 700 000 South Africans, and each patient experienced the virus differently – many paid the ultimate price. While the infection rate in the country has slowed down, pressing questions remain: How long does immunity last? What accounts for the differences in the disease’s severity?
The COVID-19 pandemic has exposed the fragility of the South African healthcare system and highlighted the need to protect the country’s frontline workers and its limited healthcare resources. It has also brought renewed attention to the working conditions experienced by frontline healthcare workers.
An intercontinental research team from Brazil, India and South Africa, comprising researchers from the University of Cape Town (UCT), has been announced as an IChemE Global Awards 2020 finalist in the Energy category for their Decentralised Diesel system, which aims to produce fuel from waste.
The University of Cape Town (UCT), situated on land below Huri ǂoaxa (Hoerikwaggo or the mountain in the sea) that was once home to the Khoi and San, marked a milestone on its transformation journey with the launch of the Khoi and San Centre on 21 September.
Two University of Cape Town (UCT) researchers have been selected as finalists for the esteemed Newton Prize 2020.
The University of Cape Town (UCT) mourns the passing of distinguished human rights lawyer, liberation struggle veteran and honorary doctorate recipient Advocate George Bizos.
South Africa has joined global counterparts in search for a COVID-19 vaccine and the University of Cape Town (UCT) is lending a hand, participating in three international trials in the country, alongside several other universities.
Scientists are disappointed, but not deterred by news that the massive HIV vaccine trial, HVTN 702, has been abandoned early for failing to stop HIV infections.